HEMAB THERAPEUTICS HLDGS INC (COAG): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in COAG. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
9
13F filers
Aggregate Value
$40.6M
Across holders
Last Price
$46.67
2026-08-24
Sector
GICS
Quarterly fund activity9 increased0 reduced0 exited
Institutional Holders of COAG
9 holders
ManagerTypeSharesMarket Value% of Total% of PortfolioActionQoQ ChangeQuarter
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund523K$19.2M47.3%0.0%AddedQ2 2026
ExodusPoint Capital Management, LP
CIK 0001736225
Hedge Fund218K$8.0M19.7%0.1%AddedQ2 2026
MARSHALL WACE, LLP
CIK 0001318757
Hedge Fund155K$5.7M14.0%0.0%AddedQ2 2026
Woodline Partners LP
CIK 0001784547
Hedge Fund150K$5.5M13.6%0.0%AddedQ2 2026
SOROS FUND MANAGEMENT LLC
CIK 0001029160
Family Office25K$918K2.3%0.0%AddedQ2 2026
Hudson Bay Capital Management LP
CIK 0001393825
Hedge Fund12K$448K1.1%0.0%AddedQ2 2026
Schonfeld Strategic Advisors LLC
CIK 0001665241
Hedge Fund11K$397K1.0%0.0%AddedQ2 2026
Squarepoint Ops LLC
CIK 0001642575
Hedge Fund6K$230K0.6%0.0%AddedQ2 2026
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
Hedge Fund6K$209K0.5%0.0%AddedQ2 2026
Loading recent insider activity…